122 related articles for article (PubMed ID: 20025190)
1. [Impact of access to antiretroviral therapy in Côte d'Ivoire].
Eholié SP; Tanon KA; Folquet-Amorissani M; Ouattara I; Aba YT; Traoré-Ettiegne V; Kakou AR; Aoussi E; Anglaret X; Bissagnéné E
Med Trop (Mars); 2009 Oct; 69(5):520-4. PubMed ID: 20025190
[TBL] [Abstract][Full Text] [Related]
2. Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Côte d'Ivoire.
Seyler C; Anglaret X; Dakoury-Dogbo N; Messou E; Touré S; Danel C; Diakité N; Daudié A; Inwoley A; Maurice C; Tonwe-Gold B; Rouet F; N'Dri-Yoman T; Salamon R;
Antivir Ther; 2003 Oct; 8(5):385-93. PubMed ID: 14640385
[TBL] [Abstract][Full Text] [Related]
3. Morbidity in HIV-1-Infected children treated or not treated with highly active antiretroviral therapy (HAART), Abidjan, Cote d'Ivoire, 2000-04.
Walenda C; Kouakoussui A; Rouet F; Wemin L; Anaky MF; Msellati P
J Trop Pediatr; 2009 Jun; 55(3):170-6. PubMed ID: 19066169
[TBL] [Abstract][Full Text] [Related]
4. [Free dispensing of antiretroviral treatments in Africa].
Taverne B
Bull Soc Pathol Exot; 2003 Aug; 96(3):241-4. PubMed ID: 14582303
[TBL] [Abstract][Full Text] [Related]
5. Quantification of HIV-1 p24 by a highly improved ELISA: an alternative to HIV-1 RNA based treatment monitoring in patients from Abidjan, Côte d'Ivoire.
Tehe A; Maurice C; Hanson DL; Borget MY; Abiola N; Maran M; Yavo D; Tomasik Z; Böni J; Schüpbach J; Nkengasong JN
J Clin Virol; 2006 Nov; 37(3):199-205. PubMed ID: 16973409
[TBL] [Abstract][Full Text] [Related]
6. Performance of drug-resistance genotypic assays among HIV-1 infected patients with predominantly CRF02_AG strains of HIV-1 in Abidjan, Cote d'Ivoire.
Bilé EC; Adjé-Touré C; Borget MY; Kalou M; Diomande F; Chorba T; Nkengasong JN
J Clin Virol; 2005 Jan; 32(1):60-6. PubMed ID: 15572008
[TBL] [Abstract][Full Text] [Related]
7. Current progress of China's free ART program.
Zhang FJ; Pan J; Yu L; Wen Y; Zhao Y
Cell Res; 2005; 15(11-12):877-82. PubMed ID: 16354563
[TBL] [Abstract][Full Text] [Related]
8. Acceptance of HIV in Cote d'Ivoire earns praise.
AIDS Wkly Plus; 1996 Apr; ():15-6. PubMed ID: 12290906
[TBL] [Abstract][Full Text] [Related]
9. Operational assessment of access to ART in rural Africa: the example of Kisantu in Democratic Republic of the Congo.
Van Rompaey S; Kimfuta J; Kimbondo P; Monn C; Buvé A
AIDS Care; 2011 Jun; 23(6):686-93. PubMed ID: 21390887
[TBL] [Abstract][Full Text] [Related]
10. Free care at the point of service delivery: a key component for reaching universal access to HIV/AIDS treatment in developing countries.
Souteyrand YP; Collard V; Moatti JP; Grubb I; Guerma T
AIDS; 2008 Jul; 22 Suppl 1():S161-8. PubMed ID: 18664948
[TBL] [Abstract][Full Text] [Related]
11. Two-months-off, four-months-on antiretroviral regimen increases the risk of resistance, compared with continuous therapy: a randomized trial involving West African adults.
Danel C; Moh R; Chaix ML; Gabillard D; Gnokoro J; Diby CJ; Toni T; Dohoun L; Rouzioux C; Bissagnene E; Salamon R; Anglaret X;
J Infect Dis; 2009 Jan; 199(1):66-76. PubMed ID: 18986246
[TBL] [Abstract][Full Text] [Related]
12. Drugs for the developing world.
GMHC Treat Issues; 1997-1998 Winter; 12(1):32. PubMed ID: 11364989
[TBL] [Abstract][Full Text] [Related]
13. Recurrent costs of HIV/AIDS-related health services in Rwanda: implications for financing.
Quentin W; König HH; Schmidt JO; Kalk A
Trop Med Int Health; 2008 Oct; 13(10):1245-56. PubMed ID: 18721185
[TBL] [Abstract][Full Text] [Related]
14. The impact of Global Health Initiatives at national and sub-national level - a policy analysis of their role in implementation processes of antiretroviral treatment (ART) roll-out in Zambia and South Africa.
Hanefeld J
AIDS Care; 2010; 22 Suppl 1():93-102. PubMed ID: 20680864
[TBL] [Abstract][Full Text] [Related]
15. Cote d'Ivoire: a case study on the impact of HIV / AIDS on health services and households.
AIDS Anal Afr; 1998 Feb; 8(1):2-3. PubMed ID: 12293288
[TBL] [Abstract][Full Text] [Related]
16. Drug companies, UNAIDS make drugs available.
AIDS Alert; 1998 Jan; 13(1):3. PubMed ID: 11364863
[TBL] [Abstract][Full Text] [Related]
17. Assessment of a national monitoring and evaluation system for rapid expansion of antiretroviral treatment in Malawi.
Lowrance D; Filler S; Makombe S; Harries A; Aberle-Grasse J; Hochgesang M; Libamba E
Trop Med Int Health; 2007 Mar; 12(3):377-81. PubMed ID: 17313509
[TBL] [Abstract][Full Text] [Related]
18. Sociodemographic factors associated with participation by HIV-1-positive pregnant women in an intervention to prevent mother-to-child transmission of HIV in Cote d'Ivoire.
Painter TM; Diaby KL; Matia DM; Lin LS; Sibailly TS; Kouassims MK; Ekpini ER; Roels TH; Wiktor SZ
Int J STD AIDS; 2005 Mar; 16(3):237-42. PubMed ID: 15829025
[TBL] [Abstract][Full Text] [Related]
19. Progress of the National Pediatric Free Antiretroviral Therapy program in China.
Zhao Y; Sun X; He Y; Tang Z; Peng G; Liu A; Qiao X; Li H; Chen Z; Dou Z; Ma Y; Liu Z; Zhang F
AIDS Care; 2010 Oct; 22(10):1182-8. PubMed ID: 20665285
[TBL] [Abstract][Full Text] [Related]
20. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D
Antivir Ther; 2008; 13 Suppl 2():15-23. PubMed ID: 18575188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
